nodes	percent_of_prediction	percent_of_DWPC	metapath
Propylhexedrine—SLC18A2—telencephalic ventricle—malignant glioma	0.283	0.377	CbGeAlD
Propylhexedrine—TAAR1—central nervous system—malignant glioma	0.114	0.151	CbGeAlD
Propylhexedrine—SLC18A2—brainstem—malignant glioma	0.0766	0.102	CbGeAlD
Propylhexedrine—SLC18A2—telencephalon—malignant glioma	0.0679	0.0905	CbGeAlD
Propylhexedrine—SLC18A2—medulla oblongata—malignant glioma	0.0534	0.0711	CbGeAlD
Propylhexedrine—SLC18A2—midbrain—malignant glioma	0.0488	0.065	CbGeAlD
Propylhexedrine—SLC18A2—central nervous system—malignant glioma	0.0386	0.0515	CbGeAlD
Propylhexedrine—SLC18A2—cerebellum—malignant glioma	0.0377	0.0503	CbGeAlD
Propylhexedrine—SLC18A2—brain—malignant glioma	0.0307	0.0409	CbGeAlD
Propylhexedrine—SLC18A2—Synaptic Vesicle Pathway—SYP—malignant glioma	0.025	0.1	CbGpPWpGaD
Propylhexedrine—SLC18A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—malignant glioma	0.0171	0.0684	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—SOX2—malignant glioma	0.0166	0.0666	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—SLC6A3—malignant glioma	0.0119	0.0475	CbGpPWpGaD
Propylhexedrine—SLC18A2—Amine compound SLC transporters—SLC6A3—malignant glioma	0.0119	0.0475	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CCR4—malignant glioma	0.00563	0.0225	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—APOD—malignant glioma	0.00471	0.0189	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00464	0.0186	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CCR4—malignant glioma	0.00428	0.0172	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.00418	0.0168	CbGpPWpGaD
Propylhexedrine—SLC18A2—Dopaminergic Neurogenesis—STAT3—malignant glioma	0.00405	0.0162	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.00382	0.0153	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LATS2—malignant glioma	0.00366	0.0147	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.00348	0.0139	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CXCR3—malignant glioma	0.00318	0.0128	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—COX8A—malignant glioma	0.00308	0.0123	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—BDKRB2—malignant glioma	0.00291	0.0117	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—FTH1—malignant glioma	0.00281	0.0113	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—LATS1—malignant glioma	0.00277	0.0111	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—BCHE—malignant glioma	0.00276	0.0111	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—KNG1—malignant glioma	0.00265	0.0106	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—SLC6A3—malignant glioma	0.0026	0.0104	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	0.00246	0.00985	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—CCR4—malignant glioma	0.00242	0.0097	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—APOD—malignant glioma	0.00239	0.00958	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—F2—malignant glioma	0.00225	0.00901	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	0.00221	0.00887	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CCR4—malignant glioma	0.0022	0.00881	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—BCHE—malignant glioma	0.00212	0.00848	CbGpPWpGaD
Propylhexedrine—SLC18A2—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	0.00211	0.00844	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—SLC6A3—malignant glioma	0.00199	0.00798	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MDK—malignant glioma	0.00187	0.00751	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—CXCR3—malignant glioma	0.0018	0.00721	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—DTX1—malignant glioma	0.00179	0.00716	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—F2—malignant glioma	0.00171	0.00686	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—BDKRB2—malignant glioma	0.00165	0.00659	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CXCR3—malignant glioma	0.00163	0.00655	CbGpPWpGaD
Propylhexedrine—TAAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	0.00158	0.00635	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—KNG1—malignant glioma	0.0015	0.006	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—BDKRB2—malignant glioma	0.00149	0.00599	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SUFU—malignant glioma	0.00142	0.00569	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.00141	0.00565	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HEY2—malignant glioma	0.0014	0.00562	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—GFAP—malignant glioma	0.00137	0.00549	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—KNG1—malignant glioma	0.00136	0.00545	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SPHK1—malignant glioma	0.00133	0.00531	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HEY1—malignant glioma	0.0013	0.0052	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CCR4—malignant glioma	0.0013	0.0052	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HIST1H3B—malignant glioma	0.00126	0.00506	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—TFRC—malignant glioma	0.00122	0.00491	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR ligand binding—CXCL8—malignant glioma	0.00121	0.00484	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—MMP3—malignant glioma	0.0012	0.00483	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.00118	0.00473	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.00118	0.00472	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—JAG2—malignant glioma	0.00115	0.00462	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	0.00112	0.00451	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—BRAF—malignant glioma	0.00108	0.00433	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	0.00107	0.00429	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—H3F3A—malignant glioma	0.000975	0.00391	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—F2—malignant glioma	0.000968	0.00388	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CXCR3—malignant glioma	0.000965	0.00387	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NTRK2—malignant glioma	0.000939	0.00376	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—YWHAE—malignant glioma	0.000939	0.00376	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FLT1—malignant glioma	0.000935	0.00375	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—DUSP6—malignant glioma	0.000931	0.00373	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CG—malignant glioma	0.000926	0.00371	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—JAG1—malignant glioma	0.000919	0.00368	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NOTCH3—malignant glioma	0.000915	0.00367	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—MDM2—malignant glioma	0.000905	0.00363	CbGpPWpGaD
Propylhexedrine—SLC18A2—Neuronal System—RAF1—malignant glioma	0.000902	0.00361	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FBXW7—malignant glioma	0.0009	0.00361	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—BDKRB2—malignant glioma	0.000883	0.00354	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—F2—malignant glioma	0.000879	0.00352	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—AKT2—malignant glioma	0.000847	0.0034	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CG—malignant glioma	0.000841	0.00337	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PTPN11—malignant glioma	0.000826	0.00331	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NOTCH2—malignant glioma	0.000821	0.00329	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CD—malignant glioma	0.000814	0.00326	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—KNG1—malignant glioma	0.000803	0.00322	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—AKT2—malignant glioma	0.00077	0.00308	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NTRK1—malignant glioma	0.000766	0.00307	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CD—malignant glioma	0.000739	0.00296	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MMP3—malignant glioma	0.000712	0.00285	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CB—malignant glioma	0.00071	0.00284	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CDKN2B—malignant glioma	0.000705	0.00283	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTK2—malignant glioma	0.000685	0.00274	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—CXCL8—malignant glioma	0.000682	0.00273	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HES1—malignant glioma	0.000673	0.0027	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NCOR1—malignant glioma	0.000669	0.00268	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—RAF1—malignant glioma	0.00066	0.00264	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—IL2—malignant glioma	0.000652	0.00261	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CB—malignant glioma	0.000644	0.00258	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PDGFRA—malignant glioma	0.000641	0.00257	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—SPP1—malignant glioma	0.000622	0.00249	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—CXCL8—malignant glioma	0.000619	0.00248	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—IL2—malignant glioma	0.000592	0.00237	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TERT—malignant glioma	0.00059	0.00236	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PDGFB—malignant glioma	0.000576	0.00231	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGFR1—malignant glioma	0.000573	0.00229	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—HIF1A—malignant glioma	0.000564	0.00226	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CAV1—malignant glioma	0.000545	0.00219	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—KDR—malignant glioma	0.000539	0.00216	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—F2—malignant glioma	0.000519	0.00208	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FN1—malignant glioma	0.000519	0.00208	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—BAD—malignant glioma	0.000513	0.00206	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—NOTCH1—malignant glioma	0.000508	0.00204	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CD80—malignant glioma	0.000498	0.00199	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—APC—malignant glioma	0.000497	0.00199	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CG—malignant glioma	0.000497	0.00199	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—EGF—malignant glioma	0.000491	0.00197	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTPN11—malignant glioma	0.000488	0.00196	CbGpPWpGaD
Propylhexedrine—SLC18A2—Transmembrane transport of small molecules—RAF1—malignant glioma	0.000485	0.00194	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—BRAF—malignant glioma	0.000467	0.00187	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKT2—malignant glioma	0.000455	0.00182	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—EGFR—malignant glioma	0.000453	0.00181	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CD—malignant glioma	0.000437	0.00175	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—PIK3CA—malignant glioma	0.000433	0.00173	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—KRAS—malignant glioma	0.000428	0.00171	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—FGF2—malignant glioma	0.000418	0.00168	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—PIK3CA—malignant glioma	0.000393	0.00157	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MDM2—malignant glioma	0.000391	0.00157	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—RAF1—malignant glioma	0.00039	0.00156	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—ERBB2—malignant glioma	0.000386	0.00155	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CB—malignant glioma	0.000381	0.00153	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CXCL8—malignant glioma	0.000366	0.00147	CbGpPWpGaD
Propylhexedrine—TAAR1—GPCR downstream signaling—AKT1—malignant glioma	0.000353	0.00142	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—CASP3—malignant glioma	0.00035	0.0014	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—IL2—malignant glioma	0.00035	0.0014	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MMP9—malignant glioma	0.000331	0.00133	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PTEN—malignant glioma	0.000329	0.00132	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling by GPCR—AKT1—malignant glioma	0.000321	0.00129	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—VEGFA—malignant glioma	0.000297	0.00119	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—STAT3—malignant glioma	0.000294	0.00118	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—MYC—malignant glioma	0.000273	0.0011	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—EGFR—malignant glioma	0.000267	0.00107	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—KRAS—malignant glioma	0.000253	0.00101	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—PIK3CA—malignant glioma	0.000232	0.00093	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—TP53—malignant glioma	0.000225	0.0009	CbGpPWpGaD
Propylhexedrine—TAAR1—Signaling Pathways—AKT1—malignant glioma	0.00019	0.00076	CbGpPWpGaD
